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httpFamily history of aortic disease predicts disease
patterns and progression and is a signiﬁcant
inﬂuence on management strategies for patients and
their relatives
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Tara Mastracci, MD,a Adrian V. Hernandez, MD, PhD,c Christina M. Rigelsky, MS, CGC,d and
Rocio Moran, MD,d Cleveland, Ohio
Background: While a positive family history (FH) is a known risk factor for developing an aneurysm, its association with
the extent of disease has not been established. We evaluated the inﬂuence of a FH of aortic disease with respect to the
pattern and distribution of aortic aneurysms in a given patient.
Methods and Results: From November 1999 to November 2011, 1263 patients were enrolled in physician-sponsored
endovascular device trials to treat aortic aneurysms. Of the 555 patients who were alive and returning for follow-up, we
obtained 426 (77%) family histories. Three-dimensional imaging studies were used to identify the presence of aneurysms;
36% (155/426) of patients had a FH of aortic aneurysms and 5% (21/155) had isolated intracranial aneurysms. A logistic
regression model was used to compare aortic morphology between patients with a positive or negative FH for aneurysms.
Patients with a positive FH of aortic aneurysms were younger at their initial aneurysm (63 vs 70 years; P < .0001), more
frequently had proximal aortic involvement (root: odds ratio [OR], 5.4; P < .0001; ascending: OR, 2.9; P < .001;
thoracic: OR, 2.2; P [ .01) with over 50% of FH patients ultimately developing suprarenal aortic involvement
(P [ .0001) and had a greater incidence of bilateral iliac artery aneurysm (OR, 1.8; P [ .03).
Conclusions: FH is an important tool that provides insight into the expected behavior of the untreated aorta and
has signiﬁcant implications for the development of treatment strategies. These ﬁndings should be used to guide
patient’s management with regard to treatment, follow-up paradigms, genetic testing, and screening of other family
members. (J Vasc Surg 2013;58:573-81.)Aortic aneurysms and dissections claim 15,000-30,000 Current knowledge dictates that between 15% and 30% of
lives per year.1 Despite the associated morbidity and
mortality of the disease, the etiology and pathogenesis
remains elusive to clinicians in most cases. Over the last
several decades, the role of genetics in aortic aneurysms
and dissections has been increasingly appreciated.2-7 While
the deﬁned gene mutations that predispose to disease devel-
opment are still being elucidated, a positive family history
(FH) of aneurysmal disease can provide insight into which
patients are at the greatest risk for a genetic etiology.8,9the Department of Vascular Surgery,a Department of Thoracic and
ardiovascular Surgery,b Department of Qualitative Health Sciences,c
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://dx.doi.org/10.1016/j.jvs.2013.02.239patients with an aortic aneurysm and/or dissection will
have a positive FH.10-13 Although the genetic mutations
in such patients remain largely invisible, other factors, such
as a younger age of disease onset and more aggressive aneu-
rysm growth rate compared with patients without a FH of
aortic disease have been noted.11,14-16
Whether a positive FH can reveal additional informa-
tion about patients’ aortic disease has not been rigorously
studied. Based on clinical experience, it was hypothesized
that patients with a positive FH have more extensive aortic
aneurysms and a different pattern of disease than patients
with no FH. To date no studies have attempted to analyze
morphologic differences of aortic aneurysms based on
a patient’s FH. The objective of this study is to evaluate
the inﬂuence of a FH of aortic disease to determine its
impact on the pattern and extensiveness of aortic aneu-
rysms in a given patient.
METHODS
Study patients. From November 1999 to November
2011, 1263 patients were enrolled in one of three
physician-sponsored endovascular device trials (NIH no.:573
Fig 1. Overall familial incidence of aneurysmal disease in probands with aortic aneurysms. ICA, Intracranial aneurysm.
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tended to treat abdominal, thoracic, or thoracoabdominal
aortic aneurysms.Within this cohort, 555 patients were alive
and returning to the Cleveland Clinic for annual follow-up
studies. Patients were interviewed to obtain a full FH anal-
ysis to determine the presence of family members
with arterial aneurysms (aortic and/or intracranial). We
completed a detailed FH on 426 (77%) patients, while 129
patients declined or were unable to provide information.
Patients with a conﬁrmed connective tissue disease were not
included in this study. Study approval was granted by our
institutional review board, and all patients enrolled signed an
informed consent.
Study design. Details for each patient regarding their
type of aortic aneurysm, comorbidities, and outcomes were
obtained from a prospectively collected database (Oracle
Clinical). Patients were grouped based upon their FH of
aneurysmal disease: (1) FH of aortic aneurysms, (2) FH
of isolated intracranial aneurysms, and (3) no FH. Patients
with a FH of aortic aneurysms were compared with the no
FH group to determine differences in demographics, age at
aneurysm presentation, number and location of aneurysmal
segments, and frequency of previous aortic repairs. Wethen compared patients with a FH of isolated intracranial
aneurysms to the no FH patients, in a similar fashion.
Patients with a FH of aortic aneurysms were also strat-
iﬁed by the number of relatives in their FH with aortic
disease (one family member vs two or more family
members) and compared to determine if those with
a greater number of relatives had more extensive aortic
morphology. Additionally, these patients were grouped
by their degree of relatedness to affected relatives (only ﬁrst
degree: parents, siblings, children; vs only second degree:
aunts, uncles, grandparents) and similarly compared to
determine differences.
Ascertainment of FH. FHs were collected for each
patient by in-person or phone interview. The FH data
was ascertained by a clinical geneticist, genetic counselor,
research nurse, or study investigator. To standardize the
process, each research member who recorded FHs was
trained by a clinical geneticist. A FH was constructed
for each proband and data gathered on all ﬁrst, second,
and third-degree relatives. For each relative in the pedi-
gree, the age/cause of death and past medical history
speciﬁc to cardiovascular or aneurysm disease, connective
tissue disorders, and other genetic abnormalities were
Table I. Patient characteristics based on a FH of aortic aneurysms
No. FH (n ¼ 250)a FH aortic aneurysm (n ¼ 155)a P value
Age of aortic aneurysm presentation, years 69.5 6 7.8 62.8 6 10.9 <.0001b
Age at ﬁrst aortic repair, years 72.1 6 8.3 66.7 6 11.9 <.0001b
Female 41 (16) 36 (23) .09
Hypertension 212 (85) 135 (87) .5
Coronary artery disease 79 (32) 56 (36) .3
Hyperlipidemia 135 (54) 77 (50) .4
Chronic renal failure 2 (1) 2 (1) .6
Congestive heart failure 35 (14) 15 (12) .3
Myocardial infarction 81 (32) 54 (34) .7
CABG 60 (24) 31 (20) .3
PTCA 34 (14) 27 (17) .3
Peripheral vascular disease 23 (9) 14 (9) .9
Deep vein thrombosis 18 (7) 12 (7) .8
COPD 63 (25) 34 (22) .5
Cerebral vascular accident 29 (12) 19 (12) .8
Smoking
Current 42 (17) 28 (18)
Prior 170 (68) 102 (66)
Never 20 (8) 20 (13)
Unknown 18 (7) 5 (3) .3
CABG, Coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; FH, family history; PTCA, percutaneous transluminal angioplasty.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
bStatistically signiﬁcant P value.
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additional information was asked of the patient to provide
validity for the diagnosis (imaging studies, surgical
reports, death certiﬁcates, or autopsy data). Excluding
patients with cardiovascular disease, relatives reported
deceased because of sudden death with an unknown
etiology were considered to potentially have had an aneu-
rysm. The interview process deﬁned disease as the pres-
ence of aortic and/or intracranial aneurysms in any ﬁrst,
second, or third-degree relative. Family members that
were reported deceased because of sudden death with
unknown etiology were considered to potentially have
had an aneurysm.
Deﬁnition of aortic disease. A contrast-enhanced
computed tomography scan 0 to 6 months prior to the
endovascular repair was used to determine the extent and
distribution of each patient’s presenting aortic pathology.
Standardized measurements were obtained for each aortic
segment with three-dimensional imaging software and
centerline of ﬂow analysis (Tera Recon, Foster City, Calif).
Aneurysmal segments were deﬁned based on the following
anatomic region and size thresholds: aortic root (>40
mm), ascending aorta (>40 mm), aortic arch (>40 mm),
descending thoracic aorta (>40 mm), suprarenal aorta
(>32 mm, deﬁned by the diaphragm proximally), infrare-
nal aorta (>32 mm), right and left iliac arteries (>20 mm),
right and left internal iliac arteries (>10 mm), and right
and left femoral arteries (>15 mm). The patient’s pre-
senting aortic pathology was characterized based on
previously reported guidelines and nomenclature.17 The
extensiveness of aneurysmal disease was deﬁned as the
number of aneurysmal segments present in each patient
from imaging or areas of previous repair.Patient variables. Variables collected for each patient
included age at presentation of ﬁrst aneurysm, sex, present-
ing aortic pathology, location and number aneurysmal
segments, number and proximity of family members with
aneurysmal disease, details regarding pervious aortic repairs,
hypertension, coronary artery disease, hyperlipidemia,
congestive heart failure, chronic renal failure, myocardial
infarction, coronary artery bypass graft, percutaneous trans-
luminal coronary angioplasty, peripheral vascular disease,
deep vein thrombosis, chronic obstructive pulmonary
disease, cerebral vascular accident, and smoking history.
Statistical analysis. Continuous variables, presented
as mean 6 standard deviation, were compared using the
Wilcoxon rank sum test and categorical variables, presented
as percentages, were compared using the c2 test. Univariate
analyses were performed on patient characteristics and
comorbidities between patients with and without a FH
of aortic disease to determine statistically signiﬁcant differ-
ences. Variables from the univariate analysis with a P # .20
were used in a logistic regression model to compare
patients with and without a FH, and adjusted odds ratios
(ORs) and P values were calculated. Signiﬁcance was set
for P # .05 and ORs presented at 95% conﬁdence intervals
(CIs).
RESULTS
Incidence for familial aneurysmal disease. The over-
all incidence of patients with a FH for any aneurysmal
disease (aortic and/or intracranial) was 41% (176/426),
with 36% (155/426) having a FH of aortic aneurysms
and 5% (21/426) having a FH of isolated intracranial
aneurysms (Fig 1). The prevalence of dissection-related
aneurysms was 5.4% (23/42), with 16 having a FH and
Fig 2. Incidence of patients with aneurysmal segments in the aorta
based on family history (FH) of aortic disease. The asterisk repre-
sents statistically signiﬁcant differences based on adjusted P values.
Fig 3. Incidence of patients with aneurysmal segments in the
iliofemoral arteries based on family history (FH) of aortic aneu-
rysms. The asterisk represents statistically signiﬁcant differences
based on adjusted P values.
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and intracranial aneurysm and were considered part of the
FH of aortic aneurysm group.
Impact of FH of aortic disease on patient demo-
graphics. Patients with a FH of aortic aneurysms were
younger at the initial presentation of their aortic disease
and at their ﬁrst aortic repair as compared with those with
no FH (P < .001) (Table I). While a higher percentage of
females was present in the patients with a FH of aortic
disease compared with the no FH group, this did not reach
statistical signiﬁcance (FH, 23%; no FH, 16%; P ¼ .09).
Additionally, there were no statistically signiﬁcant differ-
ences in the rate of smoking, hypertension, hyperlipidemia,
coronary artery disease, and chronic obstructive pulmonary
disease. Patient demographics are presented in Table I.
Impact of a FH of aortic disease on proband. A
logistic regression model was used to determine the associ-
ation between a FH and the distribution and extensiveness
of the proband’s aneurysmal disease. Based on the univar-
iate analysis, age at aneurysm presentation and sex were
added to the model to control for confounding variables.
Our data indicates that the presence of a positive FH of
aortic aneurysms inﬂuences the pattern and anatomic distri-
bution of aneurysms in the proband’s aorta and iliofemoral
arteries. While both the FH of aortic aneurysm and no FH
groups had a similar incidence of infrarenal aneurysms (FH,
87% vs no FH, 88%; P ¼ .8), the presence of a positive FH
signiﬁcantly increased the likelihood of developing aneu-
rysmal disease in the aortic root (P < .0001), ascending
aorta (P < .0001), descending thoracic aorta (P ¼ .01),
and suprarenal aorta (P ¼ .0001) (Fig 2). Such patients
also had a signiﬁcantly greater incidence of aneurysms in
bilateral iliac arteries (P ¼ .03) and in a unilateral internal
iliac artery (P ¼ .02) (Fig 3). Adjusted ORs for developing
disease in the aorta and iliofemoral arteries based on FH are
shown in Table II.
Additionally, patients with a FH of aortic disease had
more extensive aneurysms than with no FH, as determined
by the number of aneurysmal segments present in aorta andiliofemoral arteries. Fig 4 illustrates that patients with a FH
of aortic aneurysms had a greater number of aneurysmal
segments (median, 3; interquartile range [IQR], 2-5)
compared with those with no FH (median, 2; IQR, 1-3;
P < .001). Furthermore, the frequency of previous aortic
repairs was greater in patients with a FH (41%) compared
those with no FH (24%; P ¼ .003).
Impact of a FH of intracranial aneurysms on
proband. Similar to the FH of aortic aneurysm group,
patients with a FH of isolated intracranial aneurysms (n ¼
21) presented with an aortic aneurysm at a younger age
(P ¼ .03) (Table III). Additionally, these patients more
often had proximal distribution of disease in the aortic root
(P ¼ .001), ascending aorta (P ¼ .01), and descending
thoracic aorta (P ¼ .001), compared with patients with no
FH (Table III). Patients with a FH of intracranial aneurysms
also had more extensive aneurysmal disease. As presented in
Fig 4, these patients had a greater number of aneurysmal
segments (median, 4; IQR, 1-6) that were present
throughout the aorta and iliofemoral arteries as compared to
the no FH group (median, 2; IQR, 1-3; P ¼ .002).
Impact of the number of relatives with aortic
disease on the proband. Patients with a FH of aortic
disease were dichotomized into patients with only one
affected family member (n ¼ 61) and those with two or
more affected family members (n ¼ 94) with aortic disease.
Both groups had a greater frequency of aneurysms in the
aortic root, ascending aorta, descending thoracic aorta,
suprarenal aorta, bilateral iliac arteries, and a unilateral
internal iliac artery. However, compared with patients
with only one family member with aortic disease, patients
with two or more family members had a greater likelihood
of developing disease in the aortic root (OR, 2.54; 95% CI,
1.3-5.2), suprarenal aorta (OR, 2.2; 95% CI, 1.1-4.3), and
bilateral iliac arteries (OR, 2.4; 95% CI, 1.1-5.2) (Figs 5
and 6) when compared with patients with only one rela-
tive with a positive FH.
Table II. Impact of FH of aortic disease on the distribution of aneurysms in the proband
No FH (n ¼ 250), No. % FH aortic aneurysm (n ¼ 155), No. % Adjusted P value Adjusted ORs (95% CI)
Aortic segments
Root 22 (9) 55 (35) <.0001a 5.4 (3.1-9.8)
Ascending 35 (14) 57 (37) <.0001a 2.9 (1.8-5.0)
Arch 16 (6) 25 (16) .08 1.7 (0.8-3.6)
Thoracic 50 (20) 57 (37) .01a 2.2 (1.3-3.6)
Suprarenal 83 (33) 87 (56) .0001a 2.3 (1.5-3.6)
Infrarenal 221 (88) 135 (87) .8 1.4 (0.7-2.8)
Iliofemoral segments
Iliac artery
Unilateral 50 (20) 25 (16) .75 0.9 (0.5-1.6)
Bilateral 41 (16) 41 (26) .03a 1.8 (1.0-3.0)
Internal iliac artery
Unilateral 1 (4) 18 (12) .02a 2.8 (1.2-6.5)
Bilateral 18 (7) 14 (9) .12 1.2 (0.5-2.7)
Femoral artery
Unilateral 6 (2) 7 (5) .7 1.3 (0.4-4.3)
Bilateral 4 (2) 3 (2) .7 1.3 (0.2-4.4)
CI, Conﬁdence interval; FH, family history; OR, odds ratio.
aStatistically signiﬁcant P value.
Fig 4. Box plot demonstrating the number of aneurysmal
segments present in the aorta and/or iliofemoral arteries based on
family history (FH) of aneurysmal disease. ICA, Intracranial
aneurysm.
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members with disease had even more extensive aneurysmal
disease. The median number of aneurysmal segments was 4
(IQR, 3-6) for patients with two or more family members
and was three (IQR, 2-5) for those with only one family
member (P < .008). No difference was found between
groups in the age at presentation of aortic aneurysm (two
or more family members, 62.7 6 12.1 vs one family
member, 63.4 6 9.9; P ¼.5).
Impact of proximity of relative (degree of related-
ness) on the proband. Patients with a FH of aortic disease
were dichotomized into patients with only a ﬁrst-degree
relative (n ¼ 106) and those with only a second-degree
relative (n ¼ 19). These groups were then compared to
determine differences in the distribution and extensiveness
of a proband’s aneurysmal disease. Regardless of the prox-
imity of the relative to the proband, both groups had
a similar incidence of disease in all aortic or iliofemoral
segments. Fig 7 presents the distribution of aneurysmal
disease for patients with only a ﬁrst-degree relative
compared with those with only a second-degree relative,
and no identiﬁable differences were noted.
Furthermore, the proximity of the relative to the
proband does not inﬂuence the extensiveness of disease.
Regardless if the patient had only a ﬁrst or second-degree
relative, the median number of aneurysmal segments was
three (IQR, 2-5; P ¼ .7).
DISCUSSION
Although a FH of aneurysmal disease is an established
risk factor in the development of aortic aneurysmal
disease,8,18 little has been reported on the association
between FH and the anatomic distribution and extensive-
ness of aneurysmal disease. In our investigation, precise
anatomic data of the entire aorta and the iliofemoralarteries were obtained and compared based on the presence
or absence of a FH for aortic aneurysms. Our ﬁndings
suggest that patients with a FH have (1) a younger presen-
tation of aortic disease, (2) increased number of aneurysmal
segments, (3) greater likelihood of developing aneurysmal
disease proximal to the infrarenal aorta, (4) increased
occurrence of bilateral common iliac and unilateral internal
iliac artery aneurysms, and (5) higher frequency of previous
aortic repairs. Interestingly, these trends were magniﬁed as
the number of affected family members increased and were
detected in FH patients irrespective of whether a ﬁrst or
second-degree relative was present.
Table III. Impact of FH of intracranial aneurysms on the distribution of aneurysms in the proband
No. FH
(n ¼ 250)a
FH isolated intracranial
aneurysm (n ¼ 21)a
Adjusted
P value
Adjusted ORs
(95% CI)
Age of aneurysm presentation 69.5 6 7.8 65.6 6 10.1 .03b NA
Aortic segments
Root 22 (9) 8 (38) .001b 6.8 (2.3-19.1)
Ascending 35 (14) 8 (38) .01b 3.9 (1.4-10.3)
Arch 16 (6) 3 (14) .6 2.0 (0.4-7.1)
Thoracic 50 (20) 12 (57) .001b 4.8 (1.8-13.0)
Suprarenal 83 (33) 11 (52) .3 2.1 (0.8-5.2)
Infrarenal 221 (88) 17 (81) .4 0.7 (0.2-2.7)
Iliofemoral segments
Iliac artery
Unilateral 50 (20) 2 (10) .6 0.4 (0.1-1.6)
Bilateral 41 (16) 6 (29) .2 2.0 (0.7-54)
Internal iliac artery
Unilateral 11 (4) 1 (5) .7 1.0 (0.1-5.9)
Bilateral 18 (7) 3 (14) .3 2.1 (0.5-7.2)
Femoral artery
Unilateral 6 (2) 0 (0) .9 0 (0.0-3.4)
Bilateral 4 (2) 0 (0) .7 0 (0.0-8.3)
CI, Conﬁdence interval; FH, family history; OR, odds ratio.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
bStatistically signiﬁcant P value.
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aortic aneurysm morphology (aortic vs aortoiliac involve-
ment) between patients with and without a FH of
disease.14 Unsurprisingly, no difference was found, as
they used type of repair as their anatomic surrogate rather
than precise anatomic measurements for their analysis and
provided no information above the infrarenal segment.
However, similar to our ﬁndings, they did determine that
the FH group had a younger onset of aortic disease.
More recently, Albornoz et al demonstrated that patients
with thoracic aneurysms and a positive FH have a more
aggressive growth rate of their aneurysm than in patients
with sporadic disease.11 Such ﬁndings, in addition to our
own, suggest that in patients with a positive FH, genetic
factors may prominently contribute to the degenerative
and environmental processes involved in aneurysmal path-
ogenesis than previously recognized.
The association between genetics and distribution of
aneurysmal disease is most clearly observed in syndromic
connective tissue diseases (CTDs) such as Marfans,
TGFBR1/2 mutations (eg, Loeys-Dietz), and type IV
Ehlers-Danlos syndromes. In these diseases, speciﬁcally
deﬁned genetic mutations lead to aortic pathology at a rela-
tively young age (<40 years).19 In addition, there has been
growing appreciation for another group of CTDs affecting
the proximal and thoracic aorta in whom genetic mecha-
nisms are less clearly deﬁned, termed familial thoracic aortic
aneurysm and dissection.2,4,6,7,20 In these patients, aortic
aneurysms occur at a later age than the syndromic CTDs,
albeit younger than in sporadic cases. Furthermore, there
appears to be a group of patients with abdominal aortic
aneurysms and a strong FH but have an even more poorly
deﬁned genetic mechanism.5,21,22 These observations
provide support for the concept that there is a spectrum of
CTD, with the genetically deﬁned syndromic diseases atone end and those with an undiagnosed genetic defect but
an extensive FH at the other. Within this spectrum, the pres-
ence of a positive FHmay provide the evidence for a genetic
causation, except in cases of spontaneous mutations. Such
phenotypic variations in aortic morphology among patients
are likely due to different gene mutations, decreased pene-
trance, and variable expression,3,23,24 which ultimately has
implications on the potential beneﬁts of molecular testing
of family members as well as the overall management
strategy for the patient.
Abnormalities in connective tissues likely affect the
entire aortic tree, rendering it more vulnerable to accumu-
lated environmental and degenerative factors with
increasing age. Our data illustrate that patients with a FH
of aortic and/or intracranial aneurysms assists in identifying
patients that are at greater risk for proximal disease progres-
sion. Additionally, we noted that patients with a FH of
aortic disease have a greater occurrence of bilateral iliac
artery and unilateral internal iliac artery aneurysms. The
bilateral distribution is consistent with the idea of global
arterial susceptibility conferred by connective tissue abnor-
mality rather than sporadic disease secondary to a predom-
inantly degenerative causation. Recent investigations into
multiple familial thoracic aortic aneurysm and dissection
family members demonstrated a signiﬁcant proportion of
individuals suffering from bilateral iliac aneurysms.4,20
This further strengthens the concept that connective tissue
abnormalities from genetic mutations and positive FH are
interrelated.
Although Larsson et al suggested that having more
than one diseased relative increases the risk of developing
an aneurysm,12 no previous studies have investigated the
association between the number of affected family
members and the pattern and extent of a patient’s aneu-
rysmal disease. Our analysis illustrates that patients with
Fig 5. Incidence of aneurysmal segments in the aorta for patients
with two family members compared with patients with only one
family member with aortic disease. The asterisk represents statis-
tically signiﬁcant differences based on adjusted P values.
Fig 6. Incidence of aneurysmal segments in the iliofemoral
arteries for patients with two family members compared with
patients with only one family member with aortic disease. The
asterisk represents statistically signiﬁcant differences based on
adjusted P values.
Fig 7. Incidence of aneurysmal segments for patients with only
a ﬁrst-degree relative compared with patients with only a second-
degree relative with aortic disease. No signiﬁcant differences were
identiﬁed.
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oping an increased number of aneurysmal segments in
the aortic root, suprarenal aorta, and bilateral iliac arteries
than in patients with only one diseased relative (Figs 5
and 6). Thus, when obtaining a patient’s FH, a suspicion
for more extensive disease should be greater when a patient
has multiple affected family members.
The majority of studies to date investigating patients
with a FH of aortic disease have limited the focus to ﬁrst-
degree relatives.11,12,14,25 This may relate to a paradigm of
thinking adapted from observed autosomal dominant inher-
itance patterns in syndromic connective tissue disease. In
speculating that the inheritance patterns may be complex
with decreased penetrance, our FH analysis also included
second- and third-degree relatives. We detected no demon-
strable difference in the extensiveness or distribution of
aneurysmal disease between patients with only an affected
second-degree relative compared with only a ﬁrst-degree
relative. While the power of this analysis was limited by
the small number of patients with only an affected second-
degree relative (n ¼ 19), we believe there remains clinical
utility in obtaining family histories beyond the ﬁrst degree
to adjust follow-up and treatment paradigms accordingly.
Patients with a positive FH are generally younger and
have a greater proclivity to develop disease proximal to
the infrarenal aorta. Logically, any repair strategy must
account for these occurrences in such patients. Tradition-
ally, open repair has been the treatment of choice in young
patients with connective tissue disease related pathology.19
However, late failure in open surgical repairs of infrarenal
aortic aneurysms has been signiﬁcantly associated with
a positive FH of aneurysmal disease and more extensive
disease present at the time of the initial infrarenal repair.13
Additionally, our results indicate that patients with a FH
had a greater frequency of previous aortic repairs compared
with the no FH group, suggesting that a deﬁnitive plan for
future reinterventions must be considered during the initial
repair. Given that a FH has been shown to be a risk factorfor late failures in open repair, with the proximal anasto-
mosis being the most common site of failure, data suggests
that the aneurysmal neck in such patients is the area of
highest vulnerability.13,26 This effect may be ampliﬁed by
landing a stent graft, or sewing an anastomosis into the
aorta, which is not frankly aneurysmal but ectatic or has
irregular signs of impending dilation. In addition to other
considerations in FH patients, landing zone selection is
of paramount importance for the durability of repair.
What options will the surgeon have for repair as the initial
proximal landing zone fails? The best answer is likely avoid-
ance of the problemdtry to treat above the disease to
a level that if further failure occurs, it is simple to carry
out more proximal treatment. This would require one to
treat the entire visceral segment, rather landing somewhere
in the midst of the renal and visceral vesselsdwhether
accomplished with an endovascular or open surgical
approach. This would involve the use of fenestrations and
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allowing extension through the visceral segment, or open
surgery whereby each visceral and renal are implanted sepa-
rately into a side-arm graft. Nonetheless, progression of
disease may still lead to late failure at the proximal seal
zone, and these patients must be closely followed.
There are several limitations in this study. In our
cohort, 36% of patients had a positive FH of aortic disease,
which may reﬂect this speciﬁc referral patient population.
Since we did not have a means of conﬁrming a family
member’s aneurysmal disease, some of the historical data
may be inaccurate. Nonetheless, it seems more likely that
data would be skewed against a positive FH, given the
number of relatives who died of a “heart attack” and the
lack of imaging in all relatives. Thus, some relatives likely
had an aneurysm that was never identiﬁed. However, the
opposite was true for family members with sudden death,
where it was assumed that they did have an aortic aneu-
rysm. Of 176 patients that claimed to have a positive FH,
only 16 (9%) were due to sudden death. Although such
inclusion may be criticized in that the death may be from
other causes, particularly cardiovascular, these patients
were included in the FH group due to the high suspicion
of aneurysms in these relatives. Reassuringly, statistical
analysis of our results with and without patients with
a FH of sudden death was equivalent.
CONCLUSIONS
Traditionally, obtaining a detailed FH for patients with
an aortic aneurysm has provided two main functions: (1)
provides evidence for a potential genetic etiology of disease;
and (2) indicates the need for screening other family
members. However, this study suggests that obtaining an
accurate FH for patients with aortic disease is a much more
powerful tool than simple screening. FHcan assist in predict-
ing the potential pattern and extensiveness of the aneurysm
for a given patient. The information may alter management
strategies ensuring that clinicians aggressively “search” for
healthy aorta, given the greater potential for proximal
degeneration. Finally, FH patients provide an enticing study
group for further investigation regarding the molecular
mechanisms of their disease. Ultimately, this simple tool
(FH) will assist in the evaluation, treatment, and subsequent
follow-up of all patients with aneurysmal disease.
AUTHOR CONTRIBUTIONS
Conception and design: CB, RG, ME, TM
Analysis and interpretation: CB, RG, SW,ME, TM, CR, RM
Data collection: CB, SW, CR, RM
Writing the article: CB, RG
Critical revision of the article: RG, ME, TM, CR, RM
Final approval of the article: CB, RG, SW, ME, TM, AH,
CR, RM
Statistical analysis: CB, AH
Obtained funding: RG
Overall responsibility: RKREFERENCES
1. National Vital Statistics Reports. Available at: http://www.cdc.gov/
nchs/data/nvsr/nvsr59/nvsr59_10.pdf Accessed January 23, 2012.
2. Guo D-C, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, et al.
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic
aortic aneurysms and dissections. Nat Genet 2007;39:1488-93.
3. Inamoto S, Kwartler CS, Lafont AL, Liang YY, Fadulu VT,
Duraisamy S, et al. TGFBR2 mutations alter smooth muscle cell
phenotype and predispose to thoracic aortic aneurysms and dissections.
Cardiovasc Res 2010;88:520-9.
4. Regalado ES, Guo D-C, Villamizar C, Avidan N, Gilchrist D,
McGillivray B, et al. Exome sequencing identiﬁes SMAD3 mutations as
a cause of familial thoracic aortic aneurysm and dissection with intra-
cranial and other arterial aneurysms. Circ Res 2011;109:680-6.
5. McColgan P, Peck GE, Greenhalgh RM, Sharma P. The genetics of
abdominal aortic aneurysms: a comprehensive meta-analysis involving
eight candidate genes in over 16,700 patients. Int Surg 2009;94:350-8.
6. Boileau C, Guo D-C, Hanna N, Regalado ES, Detaint D, Gong L,
et al. TGFB2 mutations cause familial thoracic aortic aneurysms and
dissections associated with mild systemic features of Marfan syndrome.
Nat Genet 2012;44:916-21.
7. Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J,
et al. Loss-of-function mutations in TGFB2 cause a syndromic
presentation of thoracic aortic aneurysm. Nat Genet 2012;44:922-7.
8. Blanchard JF, Armenian HK, Friesen PP. Risk factors for abdominal
aortic aneurysm: results of a case-control study. Am J Epidemiol
2000;151:575-83.
9. Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP, et al.
Reconsidering the family history in primary care. J Gen Intern Med
2004;19:273-80.
10. Wanhainen A, Bergqvist D, Boman K, Nilsson TK, Rutegård J,
Björck M. Risk factors associated with abdominal aortic aneurysm:
a population-based study with historical and current data. J Vasc Surg
2005;41:390-6.
11. Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M,
Rizzo JA, et al. Familial thoracic aortic aneurysms and dissectionse
incidence, modes of inheritance, and phenotypic patterns. Ann Thorac
Surg 2006;82:1400-5.
12. Larsson E, Granath F, Swedenborg J, Hultgren R. A population-based
case-control study of the familial risk of abdominal aortic aneurysm.
J Vasc Surg 2009;49:47-50.
13. Coscas R, Greenberg RK, Mastracci TM, Eagleton M, Kang WC,
Morales C, et al. Associated factors, timing, and technical aspects of late
failure following open surgical aneurysm repairs. J Vasc Surg 2010;52:
272-81.
14. Darling RC III, Brewster DC, Darling RC, LaMuraglia GM,
Moncure AC, Cambria RP, et al. Are familial abdominal aortic aneu-
rysms different? J Vasc Surg 1989;10:39-43.
15. Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ,
Rizzo JA, et al. Familial patterns of thoracic aortic aneurysms. Arch
Surg 1999;134:361-7.
16. Baird PA, Sadovnick AD, Yee IM, Cole CW, Cole L. Sibling risks of
abdominal aortic aneurysm. Lancet 1995;346:601-4.
17. Fillinger MF, Greenberg RK, McKinsey JF, Chaikof EL. Reporting
standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg
2010;52:1022-33.
18. Johansen K, Koepsell T. Familial tendency for abdominal aortic
aneurysms. JAMA 1986;256:1934-6.
19. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF,
Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/
SCAI/SIR/STS/SVM guidelines for the diagnosis and management
of patients with thoracic aortic disease: a report of the American
College of Cardiology Foundation/American Heart Association Task
Force on Practice Guidelines, American Association for Thoracic
Surgery, American College of Radiology, American Stroke Association,
Society of Cardiovascular Anesthesiologists, Society for Cardiovascular
Angiography and Interventions, Society of Interventional Radiology,
Society of Thoracic Surgeons, and Society for Vascular Medicine.
Circulation 2010;121:266-369.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 3 Brown et al 58120. Guo D-C, Regalado ES, Minn C, Tran-Fadulu V, Coney J, Cao J, et al.
Familial thoracic aortic aneurysms and dissections: identiﬁcation of
a novel locus for stable aneurysms with a low risk for progression to
aortic dissection. Circ Cardiovasc Genet 2011;4:36-42.
21. Shibamura H, Olson JM, van Vlijmen-Van Keulen C, Buxbaum SG,
Dudek DM, Tromp G, et al. Genome scan for familial abdominal aortic
aneurysm using sex and family history as covariates suggests genetic
heterogeneity and identiﬁes linkage to chromosome 19q13. Circula-
tion 2004;109:2103-8.
22. Sandford RM, Bown MJ, London NJ, Sayers RD. The genetic basis of
abdominal aortic aneurysms: a review. Eur J Vasc Endovasc Surg
2007;33:381-90.
23. Guo D-C, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N,
Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2)cause coronary artery disease, stroke, and Moyamoya disease, along
with thoracic aortic disease. Am J Hum Genet 2009;84:617-27.
24. Milewicz DM, Kwartler CS, Papke CL, Regalado ES, Cao J, Reid AJ.
Genetic variants promoting smooth muscle cell proliferation can result
in diffuse and diverse vascular diseases: evidence for a hyperplastic
vasculomyopathy. Genet Med 2010;12:196-203.
25. Salo JA, Soisalon-Soininen S, Bondestam S, Mattila PS. Familial occur-
rence of abdominal aortic aneurysm. Ann InternMed 1999;130:637-42.
26. Baril DT, Carroccio A, Palchik E, Ellozy SH, Jacobs TS, Teodorescu V,
et al. Endovascular treatment of complicated aortic aneurysms in
patients with underlying arteriopathies. Ann Vasc Surg 2006;20:464-71.Submitted Oct 18, 2012; accepted Feb 16, 2013.
